• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

黑质回声增强在帕金森病鉴别诊断中的作用:一项荟萃分析。

Hyperechogenicity of substantia nigra for differential diagnosis of Parkinson's disease: A meta-analysis.

机构信息

Medical Student Research Committee (MSRC), Faculty of Medicine, Iran University of Medical Sciences, Tehran, Iran.

Department of Neurology and Neurosurgery, McGill University, Montreal, QC, Canada; Division of Clinical Geriatrics, Department of Neurobiology, Care Sciences, and Society (NVS), Karolinska Institute, Stockholm, Sweden.

出版信息

Parkinsonism Relat Disord. 2017 Sep;42:1-11. doi: 10.1016/j.parkreldis.2017.06.006. Epub 2017 Jun 15.

DOI:10.1016/j.parkreldis.2017.06.006
PMID:28647434
Abstract

Studies have suggested that the majority of patients with Parkinson's disease have abnormal ultrasound hyperechogenicity of the substantia nigra, and that this may be useful in diagnosis. We performed a systematic review and meta-analysis to evaluate diagnostic value of substantia nigra ultrasound to differentiate Parkinson's disease from atypical parkinsonism and from essential tremor. We systematically searched PubMed and EMBASE for relevant studies published until November 2016. Eligible articles were screened, data were extracted and study quality was scored by two independent reviewers. We applied random effect models to calculate pooled estimates for the prevalence of hyperechogenicity in each condition. For final meta-analysis, 71 articles with a total number of 5730 participants (idiopathic Parkinson's disease: 4494, atypical parkinsonism: 594, essential tremor: 642) were included. The pooled prevalence rate of hyperechogenicity was 84% (95 %CI 80-87%) in idiopathic Parkinson's disease, 28% (95% CI 20-36%) in atypical parkinsonism and 15% (95% CI 7-23%) in essential tremor. Based on our meta-analysis, substantia nigra hyperechogenecity has 75% (95% CI: 60-86%) sensitivity and 70% (95% CI: 55-81%) specificity to differentiate idiopathic Parkinson's disease from atypical parkinsonism. Sensitivity and specificity to distinguish idiopathic Parkinson's disease from essential tremor was calculated as 78% (95% CI: 69-85%) and 85% (95% CI: 77-91%), respectively. Findings from our meta-analysis showed that transcranial sonography can provide useful information to differentiate idiopathic Parkinson's disease from mimicking movement disorders, although sensitivity and specificity are suboptimal, particularly for differentiating from atypical parkinsonism.

摘要

研究表明,大多数帕金森病患者的黑质超声表现为高回声异常,这可能有助于诊断。我们进行了系统评价和荟萃分析,以评估黑质超声区分帕金森病与非典型帕金森病和特发性震颤的诊断价值。我们系统地检索了 PubMed 和 EMBASE 数据库,以获取截至 2016 年 11 月发表的相关研究。由两名独立的评审员筛选合格的文章、提取数据并对研究质量进行评分。我们应用随机效应模型计算每种情况下高回声的患病率的合并估计值。对于最终的荟萃分析,纳入了 71 篇文章,共计 5730 名参与者(特发性帕金森病:4494 名,非典型帕金森病:594 名,特发性震颤:642 名)。特发性帕金森病患者黑质高回声的总体患病率为 84%(95%CI 80-87%),非典型帕金森病患者为 28%(95%CI 20-36%),特发性震颤患者为 15%(95%CI 7-23%)。根据我们的荟萃分析,黑质高回声对区分特发性帕金森病与非典型帕金森病的敏感性为 75%(95%CI:60-86%),特异性为 70%(95%CI:55-81%)。特发性帕金森病与特发性震颤之间的敏感性和特异性分别计算为 78%(95%CI:69-85%)和 85%(95%CI:77-91%)。我们的荟萃分析结果表明,经颅超声检查可为区分特发性帕金森病与类似运动障碍的疾病提供有用的信息,尽管敏感性和特异性都不理想,特别是在区分非典型帕金森病时。

相似文献

1
Hyperechogenicity of substantia nigra for differential diagnosis of Parkinson's disease: A meta-analysis.黑质回声增强在帕金森病鉴别诊断中的作用:一项荟萃分析。
Parkinsonism Relat Disord. 2017 Sep;42:1-11. doi: 10.1016/j.parkreldis.2017.06.006. Epub 2017 Jun 15.
2
Magnetic resonance perfusion for differentiating low-grade from high-grade gliomas at first presentation.首次就诊时磁共振灌注成像用于鉴别低级别与高级别胶质瘤
Cochrane Database Syst Rev. 2018 Jan 22;1(1):CD011551. doi: 10.1002/14651858.CD011551.pub2.
3
Thoracic imaging tests for the diagnosis of COVID-19.用于 COVID-19 诊断的胸部影像学检查。
Cochrane Database Syst Rev. 2022 May 16;5(5):CD013639. doi: 10.1002/14651858.CD013639.pub5.
4
Physical exercise for people with Parkinson's disease: a systematic review and network meta-analysis.帕金森病患者的体育锻炼:系统评价与网状Meta分析
Cochrane Database Syst Rev. 2024 Apr 8;4(4):CD013856. doi: 10.1002/14651858.CD013856.pub3.
5
Atypical antipsychotics for disruptive behaviour disorders in children and youths.用于治疗儿童和青少年破坏性行为障碍的非典型抗精神病药物。
Cochrane Database Syst Rev. 2017 Aug 9;8(8):CD008559. doi: 10.1002/14651858.CD008559.pub3.
6
Physical exercise for people with Parkinson's disease: a systematic review and network meta-analysis.帕金森病患者的身体锻炼:系统评价和网络荟萃分析。
Cochrane Database Syst Rev. 2023 Jan 5;1(1):CD013856. doi: 10.1002/14651858.CD013856.pub2.
7
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
8
Antibody tests for identification of current and past infection with SARS-CoV-2.抗体检测用于鉴定 SARS-CoV-2 的现症感染和既往感染。
Cochrane Database Syst Rev. 2022 Nov 17;11(11):CD013652. doi: 10.1002/14651858.CD013652.pub2.
9
Beta-blocker therapy for tremor in Parkinson's disease.用于帕金森病震颤的β受体阻滞剂疗法。
Cochrane Database Syst Rev. 2003;2003(1):CD003361. doi: 10.1002/14651858.CD003361.
10
CSF tau and the CSF tau/ABeta ratio for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).脑脊液tau蛋白及脑脊液tau蛋白与β淀粉样蛋白比值在轻度认知障碍(MCI)患者中用于诊断阿尔茨海默病性痴呆及其他痴呆。
Cochrane Database Syst Rev. 2017 Mar 22;3(3):CD010803. doi: 10.1002/14651858.CD010803.pub2.

引用本文的文献

1
The role of neuro-imaging in multiple system atrophy.神经影像学在多系统萎缩中的作用。
J Neural Transm (Vienna). 2025 Jul 12. doi: 10.1007/s00702-025-02964-6.
2
Clinical and Genetic Characteristics of Parkinson's Disease Patients with Substantia Nigra Hyperechogenicity.黑质高回声的帕金森病患者的临床和遗传特征
Int J Mol Sci. 2025 Jun 8;26(12):5492. doi: 10.3390/ijms26125492.
3
Simple biomarkers to distinguish Parkinson's disease from its mimics in clinical practice: a comprehensive review and future directions.在临床实践中区分帕金森病与其模仿疾病的简单生物标志物:全面综述与未来方向
Front Neurol. 2024 Sep 19;15:1460576. doi: 10.3389/fneur.2024.1460576. eCollection 2024.
4
Attention-enhanced dilated convolution for Parkinson's disease detection using transcranial sonography.用于经颅超声检查帕金森病检测的注意力增强扩张卷积
Biomed Eng Online. 2024 Jul 31;23(1):76. doi: 10.1186/s12938-024-01265-5.
5
Systematic review-based guideline "Parkinson's disease" of the German Society of Neurology: diagnostic use of transcranial sonography.德国神经病学会基于系统评价的指南:帕金森病诊断用经颅超声检查。
J Neurol. 2024 Dec;271(12):7387-7401. doi: 10.1007/s00415-024-12502-1. Epub 2024 Jul 4.
6
The clinical and neuroimaging differences between vascular parkinsonism and Parkinson's disease: a case-control study.血管性帕金森病与帕金森病的临床和神经影像学差异:一项病例对照研究。
BMC Neurol. 2024 Feb 6;24(1):56. doi: 10.1186/s12883-024-03556-9.
7
Differentiating progressive supranuclear palsy from other movement disorders using transcranial sonography: a systematic review and meta-analysis.经颅超声在鉴别进行性核上性麻痹与其他运动障碍中的应用:系统评价和荟萃分析。
Neurol Sci. 2024 Feb;45(2):455-465. doi: 10.1007/s10072-023-07107-x. Epub 2023 Oct 11.
8
Exploring the genetic and genomic connection underlying neurodegeneration with brain iron accumulation and the risk for Parkinson's disease.探索脑铁沉积相关神经退行性变与帕金森病风险之间的遗传和基因组联系。
NPJ Parkinsons Dis. 2023 Apr 6;9(1):54. doi: 10.1038/s41531-023-00496-y.
9
Application and progress of transcranial substantial ultrasound in Parkinson's disease.经颅实质超声在帕金森病中的应用及进展
Front Neurol. 2022 Dec 1;13:1091895. doi: 10.3389/fneur.2022.1091895. eCollection 2022.
10
Differentiating Parkinson's Disease from Essential Tremor Using Transcranial Sonography: A Systematic Review and Meta-Analysis.经颅超声在帕金森病与特发性震颤鉴别诊断中的应用:系统评价和荟萃分析。
J Parkinsons Dis. 2022;12(4):1115-1123. doi: 10.3233/JPD-213012.